CLASS II ONGOING Device recall · Reported 12 May 2021 · FDA Enforcement Report

Implantable cardiac resynchronization therapy pacemakers (Crt-p) recalled

Medtronic Inc., Cardiac Rhythm and Heart Failure (Crhf) is recalling Implantable cardiac resynchronization therapy pacemakers (Crt-p). The recall was initiated on 6 Apr 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesall codes
Quantity recalled333408 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1526-2021
FDA event ID
87662
Classification
Class II
Status
Ongoing
Recall initiated
6 Apr 2021
FDA classified
4 May 2021
Reported
12 May 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

6 Apr 2021Recall initiated by company
4 May 2021Classified by FDA+28 days
12 May 2021Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A longevity estimation error may occur in the early years of device life when a unipolar pacing vector is programmed in the right atrial (RA) lead and/or the right ventricular (RV) lead. No other device features or therapies are impacted.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Implantable cardiac resynchronization therapy pacemakers (CRT-P) - Product Usage: used to treat arrhythmias related to bradycardia. Additionally, CRT-P devices can also provide cardiac resynchronization therapy (CRT) in treatment of heart failure. 1. Percepta family: Percepta CRT-P MRI SureScan, Percepta Quad CRT-P MRI SureScan. 2. Serena family: Serena CRT-P MRI SureScan, Serena Quad CRT-P MRI SureScan. 3. Solara family: Solara CRT-P MRI SureScan, Solara Quad CRT-P MRI SureScan.

Where it was distributed

Worldwide distribution.

Questions about this recall

Why was it recalled?

A longevity estimation error may occur in the early years of device life when a unipolar pacing vector is programmed in the right atrial (RA) lead and/or the right ventricular (RV) lead. No other device features or therapies are impacted.

Which lots are affected?

all codes

Where was it sold?

Worldwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 87662

This product is part of a recall event; the main page for the event is CareLink SmartSync Device Manager recalled by Medtronic Inc., Cardiac.

More recalls from Medtronic Inc., Cardiac Rhythm and Heart Failure (Crhf)

All 136

Other Pacemakers & Defibrillators recalls

All 494